Cargando…

Utility of non-HDL-C in predicting proteinuria remission of idiopathic membranous nephropathy: a retrospective cohort study

BACKGROUND: Idiopathic membranous nephropathy (IMN) may have various clinical outcomes. Hyperlipidemia is quite common in IMN. However, the utility of the lipid profile in predicting outcomes remains unknown. This study aimed to explore the correlation between hyperlipidemia and proteinuria remissio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Lei, Wei, Wang, Han, Min, Xu, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482680/ https://www.ncbi.nlm.nih.gov/pubmed/34587945 http://dx.doi.org/10.1186/s12944-021-01558-x

Ejemplares similares

Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission
por: Inagaki, Koji, et al.
Publicado: (2017)

Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy
por: Chen, Xinxin, et al.
Publicado: (2019)

Hypercholesterolemia Correlates With Glomerular Phospholipase A2 Receptor Deposit and Serum Anti-Phospholipase A2 Receptor Antibody and Predicts Proteinuria Outcome in Idiopathic Membranous Nephropathy
por: Dong, Lei, et al.
Publicado: (2022)

Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: an observational study
por: Kumar, Sanjeev, et al.
Publicado: (2012)

Association of the clinicopathological characteristics and proteinuria remission of pediatric IgAV with nephrotic-range proteinuria: A retrospective cohort study
por: Kang, Zhijuan, et al.
Publicado: (2022)

Treatment of Idiopathic Membranous Nephropathy for Moderate or Severe Proteinuria: A Systematic Review and Network Meta-Analysis
por: Chen, Miaomiao, et al.
Publicado: (2022)

Level of interleukin-35 in patients with idiopathic membranous nephropathy and its predictive value for remission time
por: Zhang, Na, et al.
Publicado: (2022)

Clinical Outcomes of Patients With Primary Membranous Nephropathy and Subnephrotic Proteinuria
por: He, Peng, et al.
Publicado: (2021)

Remission of Proteinuria May Protect against Progression to Chronic Kidney Disease in Pediatric-Onset IgA Nephropathy
por: Suh, Jin-Soon, et al.
Publicado: (2020)

Urinary epidermal growth factor predicts complete remission of proteinuria in Chinese children with IgA nephropathy
por: Zhou, Jianmei, et al.
Publicado: (2023)

Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study
por: Yamamoto, Ryohei, et al.
Publicado: (2022)

Continuation of immunosuppressive treatment may be necessary in IgA nephropathy patients with remission of proteinuria: Evaluation by repeat renal biopsy
por: LUO, MIAN-NA, et al.
Publicado: (2014)

Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)

Infusion of autologous bone marrow mononuclear cells leads to transient reduction in proteinuria in treatment refractory patients with Idiopathic membranous nephropathy
por: Sengupta, Upal, et al.
Publicado: (2013)

Phospholipase‐A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy
por: Xiao, Chunying, et al.
Publicado: (2020)

Diabetic Nephropathy: Proteinuria, Inflammation, and Fibrosis
por: Zheng, Shirong, et al.
Publicado: (2016)

Rapamycin Ameliorates Proteinuria and Restores Nephrin and Podocin Expression in Experimental Membranous Nephropathy
por: Stratakis, Stavros, et al.
Publicado: (2013)

Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy
por: Jullien, Perrine, et al.
Publicado: (2017)

Clinical Phenotypes and Predictors of Remission in Primary Membranous Nephropathy
por: Jurubiță, Roxana, et al.
Publicado: (2021)

Helper T Cells in Idiopathic Membranous Nephropathy
por: Zhao, Qihan, et al.
Publicado: (2021)

Urinary Cystatin C and Tubular Proteinuria Predict Progression of Diabetic Nephropathy
por: Kim, Sang Soo, et al.
Publicado: (2013)

Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy
por: Shang, Shun-Lai, et al.
Publicado: (2018)

Utility of remission criteria for the renal prognosis of IgA nephropathy
por: Matsuzaki, Keiichi, et al.
Publicado: (2021)

The role of sirolimus in proteinuria in diabetic nephropathy rats
por: Wang, JinJun, et al.
Publicado: (2017)

Bortezomib for Reduction of Proteinuria in IgA Nephropathy
por: Hartono, Choli, et al.
Publicado: (2018)

Glomerulosclerosis is a prognostic risk factor in patients with membranous nephropathy and non-nephrotic proteinuria
por: Sun, Jing, et al.
Publicado: (2023)

The Calcineurin Inhibitor Tacrolimus Reduces Proteinuria in Membranous Nephropathy Accompanied by a Decrease in Angiopoietin-Like-4
por: Peng, Lei, et al.
Publicado: (2014)

How Does Herbal Medicine Treat Idiopathic Membranous Nephropathy?
por: Feng, Zhendong, et al.
Publicado: (2020)

Effect of low-dose valsartan on proteinuria in normotensive immunoglobulin A nephropathy with minimal proteinuria: a randomized trial
por: Jo, Young-Il, et al.
Publicado: (2016)

Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients
por: Qin, Hua-Zhang, et al.
Publicado: (2017)

Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan
por: Yamaguchi, Makoto, et al.
Publicado: (2018)

Construction of a Nomogram Discriminating Malignancy-Associated Membranous Nephropathy From Idiopathic Membranous Nephropathy: A Retrospective Study
por: Wang, Ting, et al.
Publicado: (2022)

Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy
por: Nam, Ki Heon, et al.
Publicado: (2014)

Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy
por: Cui, W., et al.
Publicado: (2017)

Acute Kidney Injury and Remission of Proteinuria in Minimal Change Disease
por: Yamamoto, Ryohei, et al.
Publicado: (2022)

Renal outcomes of idiopathic and atypical membranous nephropathy in adult Chinese patients: a single center retrospective cohort study
por: Jiang, Zhenbin, et al.
Publicado: (2021)

Retrospective analysis of Tripterygium wilfordii polyglycoside combined with angiotensin receptor blockers for the treatment of primary membranous nephropathy with sub-nephrotic proteinuria
por: Guo, Yuanyuan, et al.
Publicado: (2021)

Lectin Complement Pathway Activation is Associated with Massive Proteinuria in PLA2R-Positive Membranous Nephropathy: A Retrospective Study
por: Li, Jiayi, et al.
Publicado: (2023)

Serum Albumin at Partial Remission Predicts Outcomes in Membranous Nephropathy
por: Lee, Taewoo, et al.
Publicado: (2020)

Chapter 7: Idiopathic membranous nephropathy
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6kbmmo1tcem4nfkah237f6gfh0